Industry / innovation partners

RAS Has Finally Hit Pancreatic Cancer. Now Access Has to Catch Up.

Polycythemia Vera Gets a First-in-Class Option. Patients Need More Than Blood Draws.

MRSA May Have A New Weakness

HER2 Testing Just Became the Gatekeeper in Gastroesophageal Cancer

MS Gets a Cleaner BTK Signal

Mpox Finally Gets A Stockpile

Obesity drugs may move beyond appetite suppression. Moonwalk just raised $70 million to target fat tissue directly

Brain Tumour Surgery Is Getting Smaller. Access Cannot Stay Elite.

Novartis lowered Lp(a) but not cardiovascular risk. What went wrong?
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
